Abstract:An HPLC assay has been developed to measure 4-aminopyridine (4-AP) in guinea pig plasma. For the assay, all plasma samples (50 microL) were microfiltered following the addition of an internal standard (3,4-diaminopyridine). Filtrates (10 microL) were directly injected into a spherical silica column (100 x 2.1 mm; 5 microns); detection was achieved at 266 nm. Standard curves had correlation coefficients ranging from 0.9923 to 0.9992 and coefficients of variation expressed as a percentage (% CV) of below 8%. Precision was expressed as between-day and within-day variability of five test sample concentrations. Between-day % CV ranged from 4.0 to 6.5%. Within-day % CV ranged from 3.6 to 6.9%. Accuracy was assessed by examining expected within-day test sample concentrations against calculated concentrations; per cent errors were all below 10%. Stability studies demonstrated % CV below 5% after repeated freezing. The method was employed to study the pharmacokinetics of 4-AP after intravenous administration to anaesthetized guinea pigs. Serial blood samples (150 microL) were collected at predetermined time intervals up to 4 h post-4-AP (2 mg/kg, i.v.) administration. 4-AP demonstrated a biexponential decline in the plasma-concentration curve as a function of time indicating a two compartment model for this drug. Selected mean pharmacokinetic parameter estimates were alpha-half-life, 0.37 min; beta-half-life (biological half-life) for terminal slope, 109 min; and volume of distribution at steady state, 1036.18 mL/kg. 4-AP was found to rapidly and extensively partition into a peripheral tissue compartment and demonstrated a relatively long biological half-life. The findings from the current pharmacokinetic experiments support the pharmacology of 4-AP in its role for reversing saxitoxin (STX)- and tetrodotoxin (TTX)-induced diaphragmatic failure in terms of onset of action and duration of effect in anaesthetized guinea pigs.

Removal Of Endocrine-Disrupting Chemicals And Conventional Pollutants In A Continuous-Operating Activated Sludge Process Integrated With Zonation For Excess Sludge Reduction

Degradation of Endocrine-Disrupting Chemicals During Activated Sludge Reduction by Ozone.

Observations on Ozone Treatment of Excess Sludge

Sludge Treatment by O-3/H2o2 and Carbon Source Recovery

Progress and perspectives of sludge ozonation as a powerful pretreatment method for minimization of excess sludge production.

Operation Performance of an A/A/O Process Coupled with Excess Sludge Ozonation and Phosphorus Recovery: A Pilot-Scale Study

Reduction of Excess Sludge Production by Uncoupling Metabolism of TCS and OSA Process

Towards zero excess sludge discharge with built-in ozonation for wastewater biological treatment

Excess sludge conditioning with ultrasound/ozone and its effect on the anaerobic anoxic oxic process in a municipal wastewater treatment plant

REDUCTION BY SONICATION OF EXCESS SLUDGE PRODUCTION IN A CONVENTIONAL ACTIVATED SLUDGE SYSTEM: CONTINUOUS FLOW AND LAB‐SCALE REACTOR

Effect of extracellular polymeric substances on sludge reduction in the humic-activated sludge anoxic-oxic-settling-anaerobic process

Abatement technology of endocrine-disrupting chemicals (EDCs) by means of enhanced coagulation and ozonation for wastewater reuse

Effect of on-Site Sludge Reduction and Wastewater Treatment Based on Electrochemical-A/O Combined Process

Reducing excess sludge volume in sequencing batch reactor by integrating ultrasonic waves and ozonation

Analysis of sludge ozonation efficiency and its influencing factors in bubble column

Systematic analysis of biochemical performance and the microbial community of an activated sludge process using ozone-treated sludge for sludge reduction.

Sludge Reduction in a Full-scale Wastewater Treatment Plant Using Ultra-fine-and Micro-bubble Ozonation

Removal of Endocrine Disrupting Chemicals in a Large Scale Membrane Bioreactor Plant Combined with Anaerobic-Anoxic-oxic Process for Municipal Wastewater Reclamation

Holistic sludge management through ozonation: A critical review

A method for determining 4-aminopyridine in plasma: pharmacokinetics in anaesthetized guinea pigs after intravenous administration.

Degradation of Extracellular Polymeric Substances (EPS) Extracted from Activated Sludge by Low-Concentration Ozonation.